Health and Healthcare Systems

How Europe can exit the COVID-19 public health emergency

pandemic, COVID-19, exit

European countries need measures that help control transmission, regardless of emerging variants, without having to impose more severe societal restrictions. Image: Unsplash / @dustintramel

Hans Kluge
Regional Director, Europe, World Health Organization (WHO)

Listen to the article

  • High COVID-19 vaccination rates in many European countries have helped to keep hospitalisation and death rates down in recent months, and have led to an easing of pandemic restrictions.
  • Some countries are at earlier stages in the pandemic's trajectory, however, and certain sections of the population also remain more vulnerable to COVID-19, while many people have been affected by long COVID.
  • For everyone in the region to exit the pandemic, European countries need certain measures to help control transmission, regardless of emerging variants, without having to impose severe societal restrictions.

Moving into the third year of the COVID-19 pandemic, as Europe’s winter gives way to spring, it may be tempting for exhausted governments and societies alike to wish the pandemic over.

The recent surge of the highly transmissible omicron variant has led to half of the WHO European region’s 200 million confirmed COVID-19 cases recorded within the last three months. Despite this massive surge in cases, high population immunity, driven largely by successful vaccination drives, has kept hospital intensive care units manageable and case-fatality rates down. In many places now, widespread COVID-19 testing, the use of masks and any physical distancing requirements appear to be a thing of the past.

Have you read?

In other parts of WHO’s European Region, however, where vaccination rates among populations vulnerable to severe COVID-19 disease is low, omicron has often proven merciless. Moreover, given that the SARS-CoV-2 virus is continually evolving, it is entirely likely new variants of concern will emerge.

So let’s be clear: there is absolutely no room for complacency. Lockdowns may be behind us, but the impact the pandemic is having on health is most certainly not.

Measuring the trajectory of COVID-19

The omicron variant currently accounts for more than 99% of new COVID-19 infections in WHO’s European Region (see Figure 1). Moreover, a combination of factors is contributing to a new resurgence in COVID-19 morbidity in several countries (see Figure 2) – a public health burden that could have high costs if the focus on ending the global emergency is allowed to drift. Omicron’s more competitive sub-lineage, known as BA.2, is gaining ground, spurred by the relaxation of social measures and the lifting of physical distancing and mask requirements.

Omicron variant, European infection rates, surge
Figure 1: The omicron variant currently accounts for more than 99% of new COVID-19 infections in WHO’s European Region. Image: World Health Organisation, 2022

While higher levels of population immunity have meant that very high infection rates have not led to severe public impacts where vaccination uptake is low, waning immunity is a significant concern among older people or those with immune deficiencies. We cannot allow high levels of COVID-19 exposures among those whose lives would likely be at risk if they were infected.

At the same time, we must recognize that different parts of the world, including countries within WHO’s European Region, are at different points in the pandemic’s trajectory. This recognition allows countries to strategise better and plan for the longer term amid what will continue to be a protracted public health challenge. Achieving a scenario where the pandemic itself dwindles and eventually fades away, even as COVID-19 remains with us, can happen only if we do the right thing, right now.

COVID-19 resurgence, Omicron variant, European infection rates
There has been a new resurgence of COVID-19 across all age groups in Europe in recent weeks. Image: World Health Organisation, 2022

So, based on WHO’s COVID-19 Strategic Preparedness and Response Plan for 2022, here's what needs to happen in our European Region to help everyone exit this public health emergency:

  • Protect people vulnerable to severe, life-threatening disease all the more through continued use of infection prevention and control measures, vaccination, early detection and high quality of care.
  • Create stronger integrated surveillance systems that monitor and track the virus better, so we can more quickly and accurately identify its spread, as well as spot significant genomic changes that alter its characteristics significantly
  • Keep health systems’ response capacities agile and ready to surge rapidly in case a new variant of concern – or even a new virus of pandemic potential – emerges
  • Tackle the long-term impacts of the pandemic – including the looming prospect of millions of people with post-COVID condition (known as “long COVID”) – along with the backlog of public health priorities neglected during the crisis, such as childhood immunization and cancer screening.

COVID-19 will not simply vanish. And too many previous surges have swept governments and societies into often desperate policies that are not sustainable in the long term. The socioeconomic consequences of such policies have been severe, jeopardizing education, for example, and pushing millions of people into poverty. Drawing upon the often-painful lessons of the past two years, however, there is now a chance to get the upper hand by maximizing the opportunities we currently have to protect people and livelihoods.

There is absolutely no room for complacency. Lockdowns may be behind us, but the impact the pandemic is having on health is most certainly not.

Hans Kluge, WHO

If implemented as a package, the above measures will strongly contribute to ending the COVID-19 public health emergency. Countries will be better able to control transmission, regardless of emerging variants, without having to impose severe societal restrictions.

Addressing long COVID

In the longer term, we must do more for the women, men and children who face the lingering consequences of their COVID-19 infections. We still do not know enough about how or why long COVID affects certain people. This needs to change in 2022. We cannot leave behind the needs of approximately 10-20% of people who experience persistent symptoms after 12 weeks following SARS-CoV-2 infection.

Discover

How has the Forum navigated the global response to COVID-19?

It is therefore necessary to impart a triple message of hope, vigilance and solidarity:

Hope, underpinned by significant investments in health systems and resources, to strengthen the ability of countries to achieve genuine universal health coverage.

Vigilance, in the shape of better surveillance and infectious disease response, including the urgent scale-up of COVID-19 vaccination, preventive measures and access to antivirals.

Solidarity, exemplified by governments and health actors better engaging the public as vital partners in our efforts – both amid the ongoing crisis and beyond.

These three elements must be combined if we are to collectively seek a way out of the current pandemic situation and, crucially, become better prepared for the next.

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Stay up to date:

Pandemic Preparedness and Response

Share:
The Big Picture
Explore and monitor how Pandemic Preparedness and Response is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

Intelligent Clinical Trials: Using Generative AI to Fast-Track Therapeutic Innovations

2:25

Meet Liv, the AI helper supporting people recently diagnosed with dementia

About us

Engage with us

  • Sign in
  • Partner with us
  • Become a member
  • Sign up for our press releases
  • Subscribe to our newsletters
  • Contact us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2024 World Economic Forum